Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Briefly, we described GDM subtypes based on differences in insulin sensitivity and secretion indexes, and how they are associated with different outcomes at delivery (C-section, macrosomia, neonatal hypoglycaemia)19 as well as differences in maternal blood lipid profiles.20 We also demonstrated the associations between maternal circulating levels of adiponectin, TNFa and vitamin D and the risk of GDM and/or insulin sensitivity in pregnancy.2123 We investigated sleep duration in pregnancy in relation to maternal blood glucose.24 More recently, we characterised the plasma circulating microtranscriptome (microRNA) profile in pregnancy25 and identified subsets of first-trimester microRNAs associated with fasting glycaemia at the second trimester of pregnancy,26 predictive of lower insulin sensitivity in pregnancy27 and increased risk of GDM.28 The discovery of microRNAs opens a new era for disease screening and diagnostics, including for GDM and gestational hypertension.

Source: Findings to date. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits

Study design awaiting verification · BMJ Open · 2025

Original publication title

Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother: child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits

Amélie Taschereau; Myriam Doyon; Mélina Arguin; Catherine Allard; Véronique Desgagné; Anne-Marie Cote; Éric Massé; Pierre-Étienne Jacques; Patrice Perron; Marie-France Hivert; Luigi Bouchard

Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

Initiated in 2010, the Genetics of Glucose regulation in Gestation and Growth (Gen3G) prospective cohort investigates the pathophysiology of impaired glycaemic regulation in pregnancy and evaluates its impact on both the mothers and her offspring health trajectory. Follow-up visits 3 and 5 years after delivery aimed to investigate pregnancy-related risk factors such as maternal obesity and gestational hyperglycaemia in relation to the mother’s metabolic health after pregnancy, and with offspring health outcomes such as risk of obesity and neurodevelopmental problems in early childhood.

We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.

Source: Purpose

Abstract: Participants

Of the 1024 women originally recruited in the first trimester of pregnancy, we have targeted the 854 who had complete glucose tolerance test data and the 724 newborns who provided placenta and/or cord blood samples for follow-up recruitment. Of these, 695 mother: child dyads agreed to be contacted for the prospective follow-up visits. 448 and 521 mother: child dyads completed the research visits at 3 and 5 years after delivery respectively.

Source: Participants

Abstract: Findings to date

At both visits, we collected the mother’s and child’s medical history, lifestyle (using validated questionnaires), sociodemographic status, anthropometric measurements, mother’s blood samples, child’s saliva samples and growth charts. At the 5-year-old visit, we additionally collected the mother’s and child’s urine and stool samples and the child’s blood samples; we performed a 75 g oral glucose tolerance test in the mothers and assessed the body composition in children using dual-energy X-ray absorptiometry. Using the Gen3G rich longitudinal data set, we have enhanced the understanding of the pathophysiology and characterisation of the heterogeneity of gestational diabetes mellitus, and we have shown that gestational hyperglycaemia and insulin resistance are associated with offspring epigenetics (DNA methylation) variations in the placenta, cord blood and blood at 5 years of age, as well as with offspring anthropometric, metabolic and neurodevelopmental outcomes in early childhood.

Source: Findings to date

Abstract: Future plans

We are currently conducting a prospective follow-up of mothers and their children 12 years after delivery to study how prenatal and early-life metabolic factors may programme childhood adiposity and obesogenic dietary behaviours. This follow-up should be completed by the end of 2026.

Source: Future plans
Authors’ abstract

Abstract

Purpose

Initiated in 2010, the Genetics of Glucose regulation in Gestation and Growth (Gen3G) prospective cohort investigates the pathophysiology of impaired glycaemic regulation in pregnancy and evaluates its impact on both the mothers and her offspring health trajectory. Follow-up visits 3 and 5 years after delivery aimed to investigate pregnancy-related risk factors such as maternal obesity and gestational hyperglycaemia in relation to the mother’s metabolic health after pregnancy, and with offspring health outcomes such as risk of obesity and neurodevelopmental problems in early childhood.

We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.

Participants

Of the 1024 women originally recruited in the first trimester of pregnancy, we have targeted the 854 who had complete glucose tolerance test data and the 724 newborns who provided placenta and/or cord blood samples for follow-up recruitment. Of these, 695 mother: child dyads agreed to be contacted for the prospective follow-up visits. 448 and 521 mother: child dyads completed the research visits at 3 and 5 years after delivery respectively.

Findings to date

At both visits, we collected the mother’s and child’s medical history, lifestyle (using validated questionnaires), sociodemographic status, anthropometric measurements, mother’s blood samples, child’s saliva samples and growth charts. At the 5-year-old visit, we additionally collected the mother’s and child’s urine and stool samples and the child’s blood samples; we performed a 75 g oral glucose tolerance test in the mothers and assessed the body composition in children using dual-energy X-ray absorptiometry. Using the Gen3G rich longitudinal data set, we have enhanced the understanding of the pathophysiology and characterisation of the heterogeneity of gestational diabetes mellitus, and we have shown that gestational hyperglycaemia and insulin resistance are associated with offspring epigenetics (DNA methylation) variations in the placenta, cord blood and blood at 5 years of age, as well as with offspring anthropometric, metabolic and neurodevelopmental outcomes in early childhood.

Future plans

We are currently conducting a prospective follow-up of mothers and their children 12 years after delivery to study how prenatal and early-life metabolic factors may programme childhood adiposity and obesogenic dietary behaviours. This follow-up should be completed by the end of 2026.

Publication and source details

Original title: Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother: child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits

Amélie Taschereau; Myriam Doyon; Mélina Arguin; Catherine Allard; Véronique Desgagné; Anne-Marie Cote; Éric Massé; Pierre-Étienne Jacques; Patrice Perron; Marie-France Hivert; Luigi Bouchard

BMJ Open · 2025

Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

None declared.

DrLuigiBouchard; luigi.bouchard@usherbrooke.ca

PP, M-FH and LB contributed equally.

Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. http://dx.doi.org/10.13039/100008985Diabète Québec http://dx.doi.org/10.13039/100000041American Diabetes Association 1-15-ACE-26 http://dx.doi.org/10.13039/501100000156Fonds de Recherche du Québec: Santé 20697 National Institute of Health R01HD094150 http://dx.doi.org/10.13039/100009874Université de Sherbrooke http://dx.doi.org/10.13039/501100000024Canadian Institutes of Health Research MOP 115071PJT152989

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:10:34.979616+00:00

DOI: 10.1136/bmjopen-2024-093434 · PMC11931902